Cambridge Investment Research Advisors
HHS icon

Cambridge Investment Research Advisors’s Harte-Hanks HHS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,200
Closed -$12K – 2027
2017
Q2 		$12K Hold
1,200
– – ﹤0.01% 1922
2017
Q1 		$17K Hold
1,200
– – ﹤0.01% 1760
2016
Q4 		$18K Hold
1,200
– – ﹤0.01% 1654
2016
Q3 		$19K Buy
+1,200
New +$19.8K ﹤0.01% 1727
2014
Q2 		– Sell
-2,019
Closed -$178K – 1351
2014
Q1 		$178K Sell
2,019
-394
-16% -$30.7K 0.01% 1165
2013
Q4 		$189K Sell
2,413
-131
-5% -$10.7K 0.01% 1104
2013
Q3 		$225K Sell
2,544
-178
-7% -$16.3K 0.01% 975
2013
Q2 		$234K Buy
+2,722
New +$225K 0.01% 872

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cambridge Investment Research Advisors's HHS Position: Q3 2017 in Review

Cambridge Investment Research Advisors sold out of Harte-Hanks (HHS) in Q3 2017, closing a stake of 1,200 shares — an estimated $12K sold.

Cambridge Investment Research Advisors first reported a position in HHS in Q2 2013 and held it in 8 quarters. The position peaked at $234K in Q2 2013. 55 funds tracked by Wall St. Rank hold HHS as of Q3 2017.

  • Cambridge Investment Research Advisors reported no remaining Harte-Hanks position as of Q3 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,200 Harte-Hanks shares in Q3 2017, an estimated $12K.
  • Cambridge Investment Research Advisors first reported a position in Harte-Hanks in Q2 2013 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Harte-Hanks position peaked at $234K in Q2 2013.
  • 55 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.